Procter & Gamble (PG) CEO Shailesh Jejurikar Receives Award

What Happened Shailesh Jejurikar, Chairman, President & CEO and a director of Procter & Gamble (PG), received multiple restricted stock unit (RSU) awards (transaction code A — grant/award) during 2026. The filing reports grants of 38.622 RSUs (Feb 17), 45.171 RSUs (May 15), 0.169 RSUs (Jul 14) and a larger grant of 947 RSUs (Aug 6), for a total of approximately 1,030.962 RSUs. All grants were recorded at $0.00 per share in the Form 4 because these are derivative awards (contingent rights to receive common stock), not open‑market purchases.

Key Details

• Transaction dates and amounts: 2026-02-17: 38.622 RSUs; 2026-05-15: 45.171 RSUs; 2026-07-14: 0.169 RSUs; 2026-08-06: 947 RSUs. All reported with $0.00 per-share price (derivative awards).
• Filing: Form 4 filed Aug 10, 2026, covering transactions through Aug 6, 2026 (the filing date is shown on the SEC filing).
• Shares owned after the transactions: not specified in the information provided in this summary (not listed in the supplied transaction details).
• Footnotes of note in the filing:
  • F1: Includes dividend equivalents paid as RSUs settled in common stock.
  • F3/F7: Some RSUs are retirement awards — contingent rights to receive P&G common stock or cash per the issuer’s retirement program and benefit formula.
  • F4: These units generally deliver as shares on retirement unless deferred or contributed to a deferred comp account.
  • F2: Reflects an adjustment to PST through July 14, 2026.
  • F6/F5: Additional plan/price mechanics described for retirement plan holdings and conversion/exercise pricing.
• Transaction type: Awards/grants of RSUs (derivative), not purchases or sales — not an open‑market trade.

Context RSU awards are compensation/retirement-related derivative grants that convert to common stock (or cash) under plan rules and typically reflect pay and benefit policies rather than an immediate trading view by the insider. Because these items are awards (code A) and include retirement‑program language, they should be interpreted as compensation/benefit transactions rather than direct buy/sell signals. Check the full Form 4 for exact plan terms and any additional details on timing, vesting, or settlement.